The traditionally simple model of pharmaceutical distribution in Europe has changed dramatically in recent years. Increasing product diversion and intensifying use of discounts and claw-backs have created an exponentially complicated trading environment. There is now a multitude of distribution channels disrupting product flows, challenging the supply chain and undermining drug integrity. Supply is therefore becoming far more complex - and an increasing source of competitive advantage.
Some of the leading pharmaceutical organisations have begun to challenge the status quo by looking for new distribution models and different ways of managing their external supply chain. Many, however, are only just coming to realise that that distribution or supply chain management is something that they should think about strategically.
IMS believes a holistic approach is required to respond to the challenge of managing for parallel trade. From measurement right through to optimum management of key processes IMS can successfully partner with you to provide measured and manageable responses to suit your individual needs.
"We were sceptical at first - we already had a supply integrity policy for one of our leading products and that had been well implemented. However the IMS team stimulated us to find many ways in which we could do better and helped us to put these in place. We have a new supply policy, more effective performance monitoring, a better defined legal position and greater cohesion amongst the European affiliates.
Our prime goal was to protect the integrity of the product and, therefore, the patient, but the economic benefits of more effective process in this area tend to be immediate. We are expecting to save $10million in recouped revenues over the next year"
Cross-Border Trade Director for Europe of leading US pharmaco
IMS has been at the forefront of these developments for several years. We have a proven approach and have completed many engagements with our pharmaceutical clients to better understand and manage for improved efficiency in supply chain management. Our programmes have ranged from understanding and benchmarking best practice in supply management right through to more complete end-to-end solutions around measurement and process and organisational change. Our clients include the top 10 pharma as well as medium and small organisations alike.
